-
Mashup Score: 3INSPIRE Trial Investigates Immunotherapy for Molecularly Selected Advanced Prostate Cancer - Niven Mehra - 8 hour(s) ago
Neeraj Agarwal interviews Niven Mehra about the INSPIRE trial. The study examines the efficacy of nivolumab and ipilimumab combination therapy in molecularly selected patients with metastatic castration-resistant prostate cancer (mCRPC). Dr. Mehra discusses the trial’s design, which focuses on four subgroups: mismatch repair deficiency, high tumor mutational burden, CDK12 inactivation, and BRCA2…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0States Must Modernize Public Health Data Reporting—New Report Finds Promising Practices - 10 hour(s) ago
Infectious diseases can move fast, spreading from person to person within days or sometimes mere hours. To effectively identify and reduce the spread of communicable diseases and other health threats, public health departments need timely, standardized, and complete data from doctors, hospitals, and other health care providers. But this critical information is often incorrect, delayed, or simply unavailable, and a new report from The Pew Charitable Trusts helps shed some light on why.
Source: www.pewtrusts.orgCategories: General Medicine News, General NewsTweet
-
Mashup Score: 3Payback: Tracking the Opioid Settlement Cash - 10 hour(s) ago
Payback Tracking the Opioid Settlement Cash Opioid manufacturers, distributors, and retailers are paying more than $54 billion in restitution to settle lawsuits about their role in the overdose epi…
Source: kffhealthnews.orgCategories: General Medicine News, General NewsTweet-
.@netflix's Painkiller depicts some of the origins of America's opioid crisis. Opioid manufacturers, distributors, & retailers are paying $54B+ in restitution to settle lawsuits. @aneripattani is tracking how state & local governments are using the money: https://t.co/8yTInlajB7 https://t.co/LQ0u62TeM1
-
-
Mashup Score: 4Traction Therapy Helps Men Regain Penile Length After Prostate Cancer Treatment - Amy Pearlman - 11 hour(s) ago
Amy Pearlman discusses penile traction therapy using the RestoreX device, a second-generation technology designed to address penile length changes after prostate cancer treatment. Dr. Pearlman explains how this device, developed by Dr. Landon Trost at Mayo Clinic, offers advantages over first-generation devices through its dynamic stretching capabilities and shorter required usage times. The…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Midwives Blame California Rules for Hampering Birth Centers Amid Maternity Care Crisis - KFF Health News - 12 hour(s) ago
Birth centers, where midwives deliver babies with emergency backup from hospitals, can offer an alternative for families as hospitals close maternity units. But the state’s stiff regulations and what many call a dysfunctional licensing process are hobbling new initiatives and forcing some facilities to shut down.
Source: kffhealthnews.orgCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1Pharmalittle: We're reading about lower-priced Zepbound vials, monkey shipments from Cambodia, and more - 14 hour(s) ago
Lilly is considering expanding the availability of lower-priced vials of its blockbuster obesity drug Zepbound
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2Birth Defects: MedlinePlus - 14 hour(s) ago
A birth defect is a problem that happens while a baby is developing in the mother’s body. Learn about the different types of birth defects, their treatments, and how some kinds can be prevented.
Source: medlineplus.govCategories: General Medicine News, General NewsTweet
-
Mashup Score: 15Phase 3 CLARIFY Trial Investigates 64Cu-SAR-bisPSMA PET for Improved Prostate Cancer Detection - Louise Emmett - 1 day(s) ago
Louise Emmett discusses the novel copper-64 bisPSMA agent for prostate cancer imaging. She explains its unique features, including a 12-hour half-life and bifid peptide structure, which potentially offer improved imaging characteristics over existing PSMA agents. Dr. Emmett highlights early study results showing higher intensity uptake in cancer cells compared to gallium PSMA-11. The…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1
Officials who oversee an international treaty governing endangered species recommended suspending shipments of long-tailed macaques — which are regularly used in medical research — from Cambodia.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 4Advances and Challenges in High-Risk CSPC: A Multidisciplinary Approach to Patient Management - Paul Sieber - 1 day(s) ago
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Paul Sieber, MD, FACS, Keystone, Urology Specialists, Lancaster, PA Neal D. Shore, MD, FACS, Medical Director, Carolina Urologic Research Center, Atlantic Urology Clinics, Chief Medical Officer,…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
#INSPIRE trial investigates immunotherapy for molecularly selected advanced #ProstateCancer. @NivenMehra @radboudumc joins @neerajaiims @huntsmancancer to discuss the efficacy of nivo + ipi combination therapy in molecularly selected patients with #mCRPC > https://t.co/Rd6NEgCfjT https://t.co/mn9CZ5cAHo